Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ML-04A in Symptomatic Benign Prostatic Hyperplasia
NCT00044226Phase 2Unknown
- Sponsor
- Milkhaus Laboratory
- Start
- Apr 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human chorionic gonadotropin in benign prostatic hyperplasia (BPH), sponsored by Milkhaus Laboratory. Status: unknown.
02
Drugs
human chorionic gonadotropin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00044226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044226.